Everlab, a health tech company based in Melbourne, has raised $10 million in seed funding to help it move forward with its goal of changing how preventive healthcare works.
Health Technology Insights: Encompass Health to Build Rehab Hospital in Cleveland, TN
The funding was led by Left Lane Capital and will be used to expand Everlab’s network of clinics, grow its team of engineers and doctors, and improve its AI systems. The company wants to create a global platform that focuses on finding diseases early and taking action before problems start.
This approach aims to help people live longer and healthier lives by offering practical and widely available preventive solutions. Everlab combines advanced testing methods, automation, and smart ways to manage clinical care. This helps give patients deeply personal health information that can spot the risk of illness long before any symptoms appear. The company is dedicated to making preventive healthcare not just a dream, but something that can be used by people from all backgrounds.
“We believe everyone deserves access to world-class preventive care,” said Marc Hermann, Founder and CEO of Everlab.
Health Technology Insights: Ampersand Capital Invests in CurTec Packaging Leader
Laura Sillman, a Principal at Left Lane Capital, said, “Preventive care has always been a great idea in medicine, but it hasn’t been easy to make into a real business. Everlab has created a product and business model that makes preventive care possible on a large scale. We’re excited to support them as they build a platform that sets a new standard in the field. ” Everlab’s method goes beyond treating diseases once they appear. Instead, the platform helps both patients and doctors take action early, which can lower healthcare costs over time and lead to better health results.
This new investment will help Everlab work toward becoming a top leader in global preventive care by making high-quality, AI-powered testing and early treatment strategies more widely available.
Health Technology Insights: Fangzhou and Novo Nordisk Partner on Health Management
To participate in our interviews, please write to our HealthTech Media Room at sudipto@intentamplify.com
